These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 665845)
21. In search of treatment for tardive dyskinesia: review of the literature. Jeste DV; Wyatt RJ Schizophr Bull; 1979; 5(2):251-93. PubMed ID: 37597 [TBL] [Abstract][Full Text] [Related]
28. Clinical research techniques in tardive dyskinesia. Fann WE; Stafford JR; Malone RL; Frost JD; Richman BW Am J Psychiatry; 1977 Jul; 134(7):759-62. PubMed ID: 869052 [TBL] [Abstract][Full Text] [Related]
29. A survey of tardive dyskinesia in psychiatric outpatients. Asnis GM; Leopold MA; Duvoisin RC; Schwartz AH Am J Psychiatry; 1977 Dec; 134(12):1367-70. PubMed ID: 335900 [TBL] [Abstract][Full Text] [Related]
30. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents. Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865 [TBL] [Abstract][Full Text] [Related]
31. [Clinical aspects of tardive dyskinesias induced by neuroleptics]. Villeneuve A; Lajeunesse C Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648 [TBL] [Abstract][Full Text] [Related]
32. Neuroleptic dosage, duration, and tardive dyskinesia. Allen RE; Stimmel GL Dis Nerv Syst; 1977 May; 38(5):385-7. PubMed ID: 852370 [No Abstract] [Full Text] [Related]
33. Management of tardive dyskinesia: current update. Simpson GM; Pi EH; Sramek JJ Drugs; 1982 May; 23(5):381-93. PubMed ID: 7047137 [TBL] [Abstract][Full Text] [Related]
34. The effect of benztropine mesylate in the rabbit syndrome and tardive dyskinesia. Sovner R; Dimascio A Am J Psychiatry; 1977 Nov; 134(11):1301-2. PubMed ID: 910992 [No Abstract] [Full Text] [Related]
35. [Neuroleptic tardive dyskinesias. Completion of the inquiry regarding 1,480 psychiatric hospital patients]. Bourgeois M; Boueilh P; Peyre C; Gauthier-Bernard F Ann Med Psychol (Paris); 1977 Apr; 1(4):660-79. PubMed ID: 603190 [No Abstract] [Full Text] [Related]
36. Orofacial and respiratory tardive dyskinesia: potential side effects of 2-dimethylaminoethanol (deanol)? Haug BA; Holzgraefe M Eur Neurol; 1991; 31(6):423-5. PubMed ID: 1756771 [TBL] [Abstract][Full Text] [Related]
37. Letter: Deanol in tardive dyskinesia. Tarsy D N Engl J Med; 1974 Dec; 291(26):1416. PubMed ID: 4427649 [No Abstract] [Full Text] [Related]
38. Tardive dyskinesia: is it or is it not? A review of the problems in diagnosis and a case study. Asnis GM Dis Nerv Syst; 1977 Oct; 38(10):856-9. PubMed ID: 908251 [No Abstract] [Full Text] [Related]
39. Epidemiology of tardive dyskinesia. Part II. Jus A; Pineau R; Lachance R; Pelchat G; Jus K; Pires P; Villeneuve R Dis Nerv Syst; 1976 May; 37(5):257-61. PubMed ID: 1261344 [TBL] [Abstract][Full Text] [Related]
40. Double blind controlled trial of deanol in tardive dyskinesia. George J; Pridmore S; Aldous D Aust N Z J Psychiatry; 1981 Mar; 15(1):68-71. PubMed ID: 6942835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]